reports
- GlobalData Healthcare Department
Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Rev...
Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. Myriad Genetics Inc Key Recent Developments: Oct 02,2017: Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month Aug 08,2017: Myriad Genetics Reports ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.